Ahmed Amine Khamlichi

Ahmed Amine Khamlichi

Auto-generated profile, based on publicly available information

Ahmed Amine Khamlichi

Institut de Pharmacologie et de Biologie Structurale (IPBS), CNRS UMR5089, Université de Toulouse, Toulouse, France

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2001 in Immunity
Verified
Journal Article
Closed access
EPEric Pinaud
Eric Pinaud
AKAhmed Amine Khamlichi
Ahmed Amine Khamlichi
CMCaroline Le Morvan
Caroline Le Morvan
MDMireille Drouet
Mireille Drouet
VNValérie Nalesso
Valérie Nalesso
Michel CognéMichel Cogné
Michel Cogné

13 July 2009 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
LWLili Wang
Lili Wang
RWRobert Wuerffel
Robert Wuerffel
SFScott Feldman
Scott Feldman
AKAhmed Amine Khamlichi
Ahmed Amine Khamlichi
AKAmy L. Kenter
Amy L. Kenter
Immunoglobulin class switch recombination is governed by long-range interactions between enhancers and germline transcript promoters to activate transcription and modulate chromatin accessibility to activation-induced cytidine deaminase (AID). However, mechanisms leading to the differential targeting of AID to switch (S) regions but not to constant (CH) regions remain unclear. We show that S and CH regions are dynamically modified with histone marks that are associated with active and repressed chromatin states, respectively. Chromatin accessibility is superimposable with the activating histone modifications, which extend throughout S regions irrespective of length. High density elongating RNA polymerase II (RNAP II) is detected in S regions, suggesting that the transcription machinery has paused and stalling is abolished by deletion of the S region. We propose that RNAP II enrichment facilitates recruitment of histone modifiers to generate accessibility. Thus, the histone methylation pattern produced by transcription localizes accessible chromatin to S regions, thereby focusing AID attack.

1 October 2000 in Current Biology
Verified
Journal Article
Closed access
MBMats Bemark
Mats Bemark
AKAmine A Khamlichi
Amine A Khamlichi
SDSarah L Davies
Sarah L Davies
MNMichael S Neuberger
Michael S Neuberger

1 October 1994 in Kidney International
Verified
Journal Article
Closed access
JPJean-Louis Preud'Homme
Jean-Louis Preud'Homme
PAPierre Aucouturier
Pierre Aucouturier
GTGuy Touchard
Guy Touchard
LSLiliane Striker
Liliane Striker
AKAhmed Amine Khamlichi
Ahmed Amine Khamlichi
Michel CognéMichel Cogné
Michel Cogné

11 May 2009 in Journal of Experimental Medicine
Verified
Journal Article
Open access
DRDeepa Rajagopal
Deepa Rajagopal
RMRobert Maul
Robert Maul
AGAmalendu Ghosh
Amalendu Ghosh
TCTirtha Chakraborty
Tirtha Chakraborty
AKAhmed Amine Khamlichi
Ahmed Amine Khamlichi
PGPatricia J. Gearhart
Patricia J. Gearhart
Repetitive DNA sequences in the immunoglobulin switch μ region form RNA-containing secondary structures and undergo hypermutation by activation-induced deaminase (AID). To examine how DNA structure affects transcription and hypermutation, we mapped the position of RNA polymerase II molecules and mutations across a 5-kb region spanning the intronic enhancer to the constant μ gene. For RNA polymerase II, the distribution was determined by nuclear run-on and chromatin immunoprecipitation assays in B cells from uracil-DNA glycosylase (UNG)–deficient mice stimulated ex vivo. RNA polymerases were found at a high density in DNA flanking both sides of a 1-kb repetitive sequence that forms the core of the switch region. The pileup of polymerases was similar in unstimulated and stimulated cells from Ung−/− and Aid−/−Ung−/− mice but was absent in cells from mice with a deletion of the switch region. For mutations, DNA was sequenced from Ung−/− B cells stimulated in vivo. Surprisingly, mutations of A nucleotides, which are incorporated by DNA polymerase η, decreased 10-fold before the repetitive sequence, suggesting that the polymerase was less active in this region. We propose that altered DNA structure in the switch region pauses RNA polymerase II and limits access of DNA polymerase η during hypermutation.

4 November 1993 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
PAPierre Aucouturier
Pierre Aucouturier
AKAhmed A. Khamlichi
Ahmed A. Khamlichi
GTGuy Touchard
Guy Touchard
EJEve Justrabo
Eve Justrabo
Michel CognéMichel Cogné
Michel Cogné
JPJean-Louis Preud'Homme
Jean-Louis Preud'Homme
Light-chain amyloidosis and light-chain deposition disease are closely related processes characterized by tissue deposition of organized (fibrillar) or nonorganized material related to monoclonal immunoglobulin light chains. Both conditions can occur in patients with immunoproliferative disorders. The clinical manifestations of light-chain deposition disease result from multivisceral involvement and are heterogeneous. Rapidly progressive renal failure or the nephrotic syndrome is the most common manifestation, but heart failure, arrhythmia, liver involvement (peliosis), and neurologic disorders may also be present. These findings may be caused by structural abnormalities or unusual behavior of deposited light chains. In particular, pathogenic light chains are characterized by unusual sizes, glycosylation, variable-region subgroups, exposed hydrophobic amino acid residues, or the propensity to polymerize or aggregate1. Soon after the first description of light-chain deposition disease,2 it became apparent that heavy chains that are monoclonal in origin may be found together with light chains in the tissue of some patients3.